eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

3/2024
vol. 16
 
Share:
Share:
abstract:
Review paper

Incidence of vaginal toxicities following definitive chemoradiation in intact cervical cancer: A meta-analysis

Shraddha Raj
1
,
Rajiv Ranjan Prasad
2
,
Alok Ranjan
3

  1. State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
  2. Jay Prabha Medanta Hospital, Patna, Bihar, India
  3. All India Institute of Medical Sciences, Patna, Bihar, India
J Contemp Brachytherapy 2024; 16, 3: 241–256
Online publish date: 2024/06/29
View full text Get citation
 
Purpose:
Cervical cancer is a significant global health burden, with advancements in treatment modalities improving outcomes. However, vaginal toxicities following definitive chemoradiation remain a concern, impacting patients’ quality of life. The aim of this systematic review and meta-analysis was to estimate the incidence of vaginal toxicities, explore associated factors, and assess the relationship with radiation dose in intact cervical cancer patients undergoing radical chemoradiation.

Material and methods:
A systematic search of PubMed, Google Scholar, and Cochrane databases was conducted. Studies reporting on vaginal toxicities post-radical chemoradiation in intact cervical cancer patients were included. Data extraction and analysis were performed according to PRISMA guidelines.

Results:
Twenty-four studies with various designs were included. The meta-analysis revealed a pooled estimate of 39% (95% CI: 21-56%) for overall vaginal toxicities among cervical cancer patients following definitive chemoradiation. Vaginal stenosis was the most commonly reported toxicity, with a median incidence of 61.5% (range, 20-77.8%) across the studies. Severe toxicities (grade ≥ 3) were reported at rates of 12.74% (CTCAE v. 4.0), 0.98% (CTCAE v. 3.0), 10.41% (RTOG/EORTC), and 0% (LENT-SOMA). Factors, such as age, initial vaginal involvement, and radiation dose were associated with increased toxicity risk. Significant heterogeneity was observed in study populations and methodologies.

Conclusions:
Vaginal toxicities are common following definitive chemoradiation in intact cervical cancer patients, with vaginal stenosis being predominant. Standardization of toxicity scoring methods and radiotherapy dose reporting parameters is crucial for accurate comparison and interpretation of findings. Future research should focus on optimizing treatment strategies to minimize vaginal toxicities while maximizing efficacy and patient outcomes.

keywords:

incidence, late toxicities, cancer cervix, chemoradiation, vaginal toxicities, vaginal stenosis, vaginal shortening, radical, definitive

 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.